| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Christchurch Cardioendocrine Research Group, Department of Medicine, Christchurch School of Medicine, Christchurch 8001, New Zealand
Address all correspondence and requests for reprints to: Dr. Vicky A Cameron, Department of Medicine, Christchurch School of Medicine, P.O. Box 4345, Christchurch 8001, New Zealand. E-mail: vicky.cameron{at}chmeds.ac.nz
Cardiac gene expression of atrial natriuretic peptide (ANP) and that of
brain natriuretic peptide (BNP) are markedly elevated after myocardial
infarction. The cellular distribution and temporal responses of ANP and
BNP messenger RNA (mRNA) expression were compared by in
situ hybridization for 5 weeks after left coronary artery
ligation in sheep. Ligation resulted in highly reproducible,
transmural, left ventricular infarcts. Within the infarct, ANP mRNA
appeared from 7 days after ligation, whereas BNP expression was
undetectable in the infarct at any time. The cells synthesizing ANP
were shown by in situ hybridization and
immunocytochemistry to be fibroblasts invading the infarct. The
appearance of ANP expression coincided with the transition of these
cells to the myofibroblast phenotype. Treatment of cultured cardiac
fibroblasts with transforming growth factor-ß (10 ng/ml) induced the
expression of
-smooth muscle actin, characteristic of the
transformation to myofibroblasts, and raised ANP concentrations in the
medium. In the surviving myocardium of the left ventricle, ANP and BNP
expression increased in response to ligation, BNP mRNA was particularly
strong at the lateral margins of the infarct. In both left and right
atria, levels of BNP mRNA increased markedly over the first 18 h,
whereas levels of atrial ANP mRNA decreased over 3 days after
infarction. This is the first report of ANP expression and synthesis by
cardiac fibroblasts invading the fibrotic scar, suggesting that ANP may
be involved in regulating fibroblast proliferation during reparative
fibrosis.
This article has been cited by other articles:
![]() |
D. J. Glenn, D. Rahmutula, M. Nishimoto, F. Liang, and D. G. Gardner Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism Cardiovasc Res, November 1, 2009; 84(2): 209 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. George, B. Morrow, K. Xu, G.-H. Yi, J. Holmes, E. X. Wu, Z. Li, A. A. Protter, M. C. Oz, and J. Wang Prolonged effects of B-type natriuretic peptide infusion on cardiac remodeling after sustained myocardial injury Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H708 - H717. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Landeen, N. Aroonsakool, J. H. Haga, B. S. Hu, and W. R. Giles Sphingosine-1-phosphate receptor expression in cardiac fibroblasts is modulated by in vitro culture conditions Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2698 - H2711. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Jarvis, M. T. Rademaker, L. J. Ellmers, M. J. Currie, J. L. McKenzie, B. R. Palmer, C. M. Frampton, A. M. Richards, and V. A. Cameron Comparison of infarct-derived and control ovine cardiac myofibroblasts in culture: response to cytokines and natriuretic peptide receptor expression profiles. Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1952 - H1958. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miragoli, G. Gaudesius, and S. Rohr Electrotonic Modulation of Cardiac Impulse Conduction by Myofibroblasts Circ. Res., March 31, 2006; 98(6): 801 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Magga, M. Puhakka, S. Hietakorpi, K. Punnonen, P. Uusimaa, J. Risteli, O. Vuolteenaho, H. Ruskoaho, and K. Peuhkurinen Atrial natriuretic peptide, B-type natriuretic peptide, and serum collagen markers after acute myocardial infarction J Appl Physiol, April 1, 2004; 96(4): 1306 - 1311. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Troughton, D. L. Prior, J. J. Pereira, M. Martin, A. Fogarty, A. Morehead, T. G. Yandle, A. M. Richards, R. C. Starling, J. B. Young, et al. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function J. Am. Coll. Cardiol., February 4, 2004; 43(3): 416 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Biondo, E. J. Ehrhart, D. D. Sisson, B. J. Bulmer, H. S. A. De Morais, and P. F. Solter Immunohistochemistry of Atrial and Brain Natriuretic Peptides in Control Cats and Cats with Hypertrophic Cardiomyopathy Vet. Pathol., September 1, 2003; 40(5): 501 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Cameron and L. J. Ellmers Minireview: Natriuretic Peptides during Development of the Fetal Heart and Circulation Endocrinology, June 1, 2003; 144(6): 2191 - 2194. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Horio, T. Tokudome, T. Maki, F. Yoshihara, S.-i. Suga, T. Nishikimi, M. Kojima, Y. Kawano, and K. Kangawa Gene Expression, Secretion, and Autocrine Action of C-Type Natriuretic Peptide in Cultured Adult Rat Cardiac Fibroblasts Endocrinology, June 1, 2003; 144(6): 2279 - 2284. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsuruda, G. Boerrigter, B. K. Huntley, J. A. Noser, A. Cataliotti, L. C. Costello-Boerrigter, H. H. Chen, and J. C. Burnett Jr Brain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix Metalloproteinases Circ. Res., December 13, 2002; 91(12): 1127 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Ellmers, J. W. Knowles, H.-S. Kim, O. Smithies, N. Maeda, and V. A. Cameron Ventricular expression of natriuretic peptides in Npr1-/- mice with cardiac hypertrophy and fibrosis Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H707 - H714. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |